Use of vitamin D analogs to treat conditions related to increased oxidative stress
Patent 6262041 Issued on July 17, 2001. Estimated Expiration Date: 
April 6, 2019. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
April 6, 2019. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesMethod for therapeutically treating psoriatic arthritis using vitamin D analogues and metabolites Vitamin D3 analogs useful for reversing the photodamage in sun-exposed skin Vitamin D3 analogs useful for reversing the photodamage in sun-exposed skin Patent #: 5804574 InventorAssigneeApplicationNo. 287544 filed on 04/06/1999US Classes:514/1679,10-seco- cyclopentanohydrophenanthrene ring system (e.g., vitamin D, etc.) DOAIExaminersPrimary: Goldberg, Jerome D.Attorney, Agent or FirmInternational ClassA61K 031/59AbstractA pharmaceutical composition for reducing the rate at which skin ages or for treating cancer, acne or rosacea. The composition comprises a pharmaceutically acceptable excipient in combination with 26, 27-hexafluoro-1,25-dihydroxy vitamin D3. The composition is preferably administered topically at a concentration of about 0.0001% weight to about 0.01% weight.Other References
| |
